Previous 10 | Next 10 |
NeuroOne®#¹⁶⁰;to Participate in the 35th Annual Roth Conference PR Newswire EDEN PRAIRIE, Minn. , March 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology co...
2023-03-09 08:40:39 ET Ocean Biomedical ( OCEA ) +38% on sharing detailed research data on anti-tumor pathway discoveries and their potential for treatment of non-small cell lung cancer, metastatic melanoma, and glioblastoma by scientific co-founder. First Wave ( FWB...
NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform PR Newswire New patent adds value to NeuroOne's growing patent portfolio in the U.S. and abroad EDEN PRAIRIE, Minn. , March 7, 2023 /PRNewswire/ -- NeuroOne...
NeuroOne Medical Technologies Corporation (NMTC) Q1 2023 Earnings Conference Call February 14, 2023, 04:30 AM ET Company Participants Dave Rosa - President and CEO Ron McClurg - CFO Conference Call Participants Alex Nowak - Craig Hallum Capital Group Ben Ha...
NeuroOne Medical Technologies press release ( NASDAQ: NMTC ): Net loss was $1.7 million for the fiscal first quarter 2023, compared to a net loss of $2.8 million in the prior year period. Product revenue was $115,000 in the fiscal first quarter 2023, ...
NeuroOne® Reports First Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update PR Newswire EDEN PRAIRIE, Minn. , Feb. 14, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical...
NeuroOne® to Report First Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on February 14 PR Newswire EDEN PRAIRIE, Minn. , Feb. 9, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Com...
NeuroOne® Issues Letter to Shareholders PR Newswire Company highlights fiscal year 2022 and subsequent achievements, catalysts for fiscal year 2023 EDEN PRAIRIE, Minn. , Jan. 30, 2023 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq:...
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2022 Financial Results PR Newswire EDEN PRAIRIE, Minn. , Dec. 22, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC; "NeuroOne" or the "Company"), a medical technolo...
Palm Beach, FL – December 14, 2022 – FinancialNewsMedia.com News Commentary – A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper signaling pathway causes the heart to beat too rapi...
News, Short Squeeze, Breakout and More Instantly...
NeuroOne Medical Technologies Corporation Company Name:
NMTC Stock Symbol:
OTCMKTS Market:
NeuroOne Medical Technologies Corporation Website:
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ( ...
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF ™ Ablation System for broader adoption and awareness throughout the healthcare system EDEN ...
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological d...